# Study of Methacholine Chloride Inhalation Challenge in Children With Bronchial Asthma

> **NCT02097537** · PHASE3 · COMPLETED · sponsor: **Santen Pharmaceutical Co., Ltd.** · enrollment: 10 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Methacholine Chloride (SK-1211)

## Key facts

- **NCT ID:** NCT02097537
- **Lead sponsor:** Santen Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2014-07
- **Final completion:** —
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2017-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02097537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02097537, "Study of Methacholine Chloride Inhalation Challenge in Children With Bronchial Asthma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02097537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*